Genpact earnings calendar sets the tone, shares on NYSE radar

Genpact outlines its upcoming earnings timetable and guidance framework, with the NYSE-listed business services provider drawing attention from analysts and peers in the IT outsourcing sector.

By Mark Bergmann, Earnings & Calendar desk. Reviewed prior to publication on 2026-06-29, 18:33.

Genpact Ltd (BMG3922B1072) gives investors a clear view of its earnings rhythm, with the next quarterly update expected in early August, according to the company's investor materials and earnings calendar references on NYSE-focused data services.Genpact investor information and filings The business process management specialist's shares trade on the NYSE alongside peers such as Accenture and Cognizant in the broader IT services cohort.Nasdaq market activity overview for Genpact

Upcoming earnings dates and guidance

Genpact's last reported quarter showed the company continuing its pattern of mid-single-digit to low-double-digit revenue growth, driven by demand in digital operations and analytics services, as seen in its recent results documentation.Latest Genpact quarterly financial results The company typically reports second-quarter earnings in early August, giving investors a fixed point on the calendar for updated revenue and margin figures.

The firm has historically combined its earnings releases with reaffirmed or adjusted full-year guidance ranges, covering revenue, adjusted operating margin and adjusted earnings per share, which remain key indicators for analyst models.Genpact events and presentations archive These updates help frame expectations for the remainder of the year in a sector where contract wins and renewals can shift quarterly performance.

Analyst consensus and peer comparison

Analyst services tracking Genpact stock generally note a mixed but constructive view on the company, with a majority of published ratings clustered around Buy or Hold, reflecting steady but not spectacular growth prospects in business process outsourcing.MarketScreener consensus data for Genpact Price targets compiled across brokers often sit moderately above the current share price, signalling expectations for incremental value creation rather than sharp re-rating moves.

Genpact is often compared with Accenture, Cognizant and Infosys in analyst notes, with differentiation coming from its focus on analytics-led process transformation and longstanding client relationships in banking, insurance and industrial sectors.Reuters company profile and market commentary on Genpact For investors, the consensus landscape and sector comparison are central to assessing how any upcoming guidance change might shift sentiment around the shares on the NYSE.

How Genpact generates its revenue

Genpact earns most of its revenue through long-term contracts in business process management, combining outsourced operations with digital transformation services for large enterprises in banking, insurance, healthcare and industrial manufacturing.Genpact corporate overview and business model description Core offerings include finance and accounting services, supply chain management and customer experience operations, often supported by in-house analytics platforms.

Genpact stock and current trading venue

Genpact shares trade on the New York Stock Exchange under the ticker G, with recent prices reported in US dollars on NYSE and data platforms such as Nasdaq and Reuters.NYSE quote overview for Genpact The latest recorded trading price during the US session was 32.40 USD as of 2026-06-29, based on public market data.

Genpact at a glance

• Company: Genpact Ltd
• ISIN: BMG3922B1072
• WKN: A0J2EM
• Ticker: G
• Trading venue: NYSE
• Price (as of 2026-06-29, 18:33): 32.40 USD
• Market cap: 5.90 billion USD (as of 2026-06-29)
• Sector / industry: IT services and business process outsourcing
• Index membership: No major headline index inclusion reported
• Next earnings date: 2026-08-07

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.